MediPharm Labs Corp. wholly owned subsidiary, MediPharm Labs has received its Cannabis Research Licence under Health Canada’s Cannabis Act and Cannabis Regulations.
"This licence permits MediPharm to conduct controlled human administration trials of dried cannabis, cannabis extracts and concentrates, distillates, oil, edibles, topicals and terpenes at its state-of-the-art production facilities, built to EU-GMP standards, in Barrie following quality assurance testing," the team with the company explains. "Cannabis companies without this licence cannot use sensory experiments with taste, thus limiting their understanding of the taste profile of the raw material, in-process material and finished products."
“This licence is a game-changer for our R&D process and the timing of receipt, which coincides with the Canadian legalization of edibles, beverage-infused drinks and topicals, enables MediPharm Labs to perfect our products for human consumption,” said Pat McCutcheon, Chief Executive Officer, MediPharm Labs. “Scientific study and testing of sensory properties in our process gives us a competitive edge, one that we know consumer-packaged goods companies and licence holders selling to retail will value and employ. Understanding the multiple variables that may influence consumer preferences, while establishing scientific testing data, is key to developing innovative products that provide consumers with a “choice”, also leading to increased consumer acceptability. We see this development as a catalyst for additional sales growth and customer service.”
"Sensory evaluation is a fundamental scientific discipline used throughout the food and beverage industry to gauge human reactions to stimuli perceived through smell, sight, touch and taste," they further explain. "It will now also become an indispensable part of the process used at MediPharm as the company tests product ingredients and flavours including terpenes (the aromatic oils that give cannabis its distinctive smell) before they are used in downstream formulation processes. MediPharm already uses many other quality tests including screening for microbial and chemical contaminants."
“Canadian cannabis consumers deserve the very best experience and should expect the highest standards for taste and quality,” said Mr. McCutcheon. “They will get both when MediPharm Labs is part of the value chain.”
"The Health Canada Research Licence adds to the Company’s growing portfolio of Canadian and international licences. These licences, along with proprietary extraction processes, are among MediPharm Labs’ most coveted assets,"
For more information:
151 John Street, Barrie
+1 705 719 7425